Search Results 751-760 of 19458 for B cell lymphomas

  1. Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

    Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...

  2. Publications - Vivek N. Iyer, M.D., M.P.H. - Mayo Clinic

    Isolated Intravascular Large B-cell Lymphoma Presenting with Diffuse Ground Glass Pulmonary Infiltrates. Indian J Hematol Blood Transfus. 2016 Jun; 32 ...

  3. Living With Cancer: Lymphoma treatment options - Mayo Clinic News Network

    Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. Treatment may involve chemotherapy, immunotherapy medications, ...

  4. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

    Dr. Cerhan's team in the Lymphoma Epidemiology Lab at Mayo Clinic has expertise in cancer epidemiology, hematology, immunology, laboratory medicine and ...

  5. Science Saturday: Potential and pitfalls of gene therapy - Mayo Clinic News Network

    ... B-cell leukemias and lymphomas. Saad Kenderian, M.D.. “CAR T-cell therapy is ... The therapy relies on the insertion of genetic materials into the patient own ...

  6. Spinal Cord Lymphoma Clinical Trials - Mayo Clinic Research

    Rationale - Pomalidomide is a novel immunomodulatory agent, which has shown significant activity against CNS lymphoma in preclinical studies. Blood brain ...

  7. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.

  8. A Study of Using Bortezomib and Combination Chemotherapy in Treating Children with Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma - Mayo Clinic

    ... Lymphoma. Print details. Share; Facebook · Twitter ... lymphoma. Bortezomib may stop the growth ... Patients with mature B-cell ALL, ie, leukemia with B-cell ...

  9. Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma - Mayo Clinic

    Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma ... Nodular lymphocyte predominant Hodgkin lymphoma ... Known hepatitis B ...

  10. A Randomized, Phase III Study Comparing Alectinib with Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Patients - Mayo Clinic

    ... Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Patients. Print details. Share; Facebook · Twitter. Overview; Participation ...